Select Page

VanEck Pharmaceutical ETF PPH
86.38 -2.07 (-2.34%) Jul 29, 2025

  • Overview
  • Dividends
  • Performance
  • Calculators
  • Rolling Returns
  • Drawdowns

Overview


Fund Assets 625.05M
Expense Ratio 0.36%
Category Health
Dividend 0.41
Ex-Dividend Date Dec 27, 2024
Annualized Return (3Y) 5.61%
Annualized Return (5Y) 7.98%
Annualized Return (10Y) 3.37%
Annualized Return (15Y) 9.62%
Volume 1,242,102
Close 86.38
Previous Close 88.45
Worst 3Y Roll AR -10.97%
Worst 5Y Roll AR -8.03%
Worst 10Y Roll AR -2.42%
Worst 15Y Roll AR 3.35%
Inception Date Feb 01, 2000
--
--
loading...

Dividends


VanEck Pharmaceutical ETF (PPH) Dividend Information

VanEck Pharmaceutical ETF (PPH) dividend growth in the last 12 months is -46.61%

The trailing 12-month yield of VanEck Pharmaceutical ETF is 0.89%. its dividend history:

Pay Date Cash Amount
Dec 27, 2024 $0.411
Oct 01, 2024 $0.409
Jul 01, 2024 $0.356
Apr 01, 2024 $0.533
Dec 27, 2023 $0.307
Oct 02, 2023 $0.34
Jul 03, 2023 $0.389
Apr 03, 2023 $0.664
Dec 28, 2022 $0.24
Oct 03, 2022 $0.27

Dividend Growth History for VanEck Pharmaceutical ETF (PPH)

Year
Payout Amount
Year Start Yield
Annual Payout Growth (YoY)
CAGR to 2024
2024 $1.709 2.07% 0.53% -
2023 $1.7 2.17% 41.31% 0.53%
2022 $1.203 1.57% -3.76% 19.19%
2021 $1.25 1.88% 13.22% 10.99%
2020 $1.104 1.71% -2.82% 11.54%
2019 $1.136 2.06% 5.09% 8.51%
2018 $1.081 1.79% -5.18% 7.93%
2017 $1.14 2.13% -10.52% 5.95%
2016 $1.274 1.99% 0.87% 3.74%
2015 $1.263 1.97% 15.24% 3.42%
2014 $1.096 2.08% 5.69% 4.54%
2013 $1.037 2.57% -24.72% 4.65%
2012 $1.3775 3.74% -3.37% 1.81%
2011 $1.4255 4.36% 30.00% 1.41%
2010 $1.0965 3.27% -62.82% 3.22%
2009 $2.9495 9.46% 140.78% -3.57%
2008 $1.225 3.11% 9.91% 2.10%
2007 $1.1145 2.88% -35.35% 2.55%
2006 $1.724 4.87% 96.80% -0.05%
2005 $0.876 2.44% -6.56% 3.58%
2004 $0.9375 2.34% 18.67% 3.05%
2003 $0.79 2.07% 2.66% 3.74%
2002 $0.7695 1.56% 11.60% 3.69%
2001 $0.6895 1.23% -66.86% 4.03%
2000 $2.0805 4.56% - -0.82%

Dividend Growth Chart for VanEck Pharmaceutical ETF (PPH)

VanEck Pharmaceutical ETF (PPH) Dividend Calculator

$
Total Dividend Accrued
$ 1,460.00
Annualized Dividend Yield
10.68 %

Performance


VanEck Pharmaceutical ETF (PPH) Historical Returns And Risk Info

From 02/01/2000 to 07/29/2025, the compound annualized total return (dividend reinvested) of VanEck Pharmaceutical ETF (PPH) is 5.366%. Its cumulative total return (dividend reinvested) is 277.973%.

From 02/01/2000 to 07/29/2025, the Maximum Drawdown of VanEck Pharmaceutical ETF (PPH) is 46.4%.

From 02/01/2000 to 07/29/2025, the Sharpe Ratio of VanEck Pharmaceutical ETF (PPH) is 0.23.

From 02/01/2000 to 07/29/2025, the Annualized Standard Deviation of VanEck Pharmaceutical ETF (PPH) is 18.3%.

From 02/01/2000 to 07/29/2025, the Beta of VanEck Pharmaceutical ETF (PPH) is 1.0.

Name YTD Return 1Yr AR 3Yr AR 5Yr AR 10Yr AR 15Yr AR 20Yr AR Inception
PPH (VanEck Pharmaceutical ETF) 0.12% -6.50% 5.61% 7.98% 3.37% 9.62% 7.36% 5.46%
VGHCX (VANGUARD HEALTH CARE FUND INVESTOR SHARES) -5.34% -23.06% -5.32% -4.08% 0.77% 8.32% 6.91% 8.26%
Data as of 07/29/2025, AR inception is 02/01/2000

Return Calculator for VanEck Pharmaceutical ETF (PPH)

Start date (MM/dd/yyyy)

End date   (MM/dd/yyyy)

VanEck Pharmaceutical ETF (PPH) Historical Return Chart


Calculators


Dollar Cost Average Calculator for VanEck Pharmaceutical ETF (PPH)

Starting Amount:
Investment Length (years):
Investment Symbol:
Regular Investment Amount ($):
DCA Frequency:
Share on

Retirement Spending Calculator for VanEck Pharmaceutical ETF (PPH)

Starting Amount:
Period (Years):
Investment Portfolio or Fund:
Withdrawal Rate (%) :
%
Withdrawal Frequency:
Share on

Rolling Returns


A rolling return for a period such as 5-year, as of a specific date, represents the investment’s performance over the preceding five years leading up to that date. In the 5-year rolling chart, the value on any given date corresponds to the annualized return for the preceding 5 years up to that very date. Thus, for instance, the chart value on 8/28/2015 reflects the annualized return from 8/28/2010 to 8/28/2015. A 5-year rolling return chart for an investment (stock, fund or portfolio) depicts the return sequence of 5-year trailing returns for the dates in the chart.

These rolling returns contrast with the most recent 3, 5, 10, and 15-year returns, as they solely depict the returns for those respective periods leading up to the most recent date, without encompassing every date in the historical record.

Rolling return charts offer a more precise insight into a portfolio’s risk and return stability (including funds or individual stocks). This is particularly true when focusing on the minimal return points within a rolling return chart as a measure of a fund or a portfolio's risk. A well-known observation, often attributed to ‘Murphy’s law’, is that it tends to perform poorly when investors decide to follow an investment due to its recent strong returns. Sound familiar? Information regarding minimum rolling returns could help mitigate this predicament. Investors can opt for an investment showcasing high minimum rolling returns within their preferred holding durations. In fact, merely possessing knowledge of such minimum rolling period returns can anchor investors’ expectations.

For instance, let’s consider an investor who follows a model portfolio (or even simply purchases and holds a fund like VFINX or SPY) for 10 years. Armed with knowledge of this portfolio’s minimum 10-year rolling return since its inception date or the fund’s inception (in the case of VFINX, recognizing that the minimum 10-year rolling return since 1987 could be as low as -2.24%), the investor should reasonably anticipate the potential for the portfolio to incur losses over the forthcoming 10 years.

Minimum rolling return for a period such as 10-year offers a different and often better historical risk and return metric than other popular risk and return metrics such as Sharpe ratio, standard deviation (volatility) or maximum drawdown.

See Portfolio Calculator and Rolling Returns for more detailed description.

From 02/01/2000 to 07/29/2025, the worst annualized return of 3-year rolling returns for VanEck Pharmaceutical ETF (PPH) is -10.97%.
From 02/01/2000 to 07/29/2025, the worst annualized return of 5-year rolling returns for VanEck Pharmaceutical ETF (PPH) is -8.03%.
From 02/01/2000 to 07/29/2025, the worst annualized return of 10-year rolling returns for VanEck Pharmaceutical ETF (PPH) is -2.42%.
From 02/01/2000 to 07/29/2025, the worst annualized return of 20-year rolling returns for VanEck Pharmaceutical ETF (PPH) is 3.39%.

Drawdowns


VanEck Pharmaceutical ETF (PPH) Maximum Drawdown




Related Articles for VanEck Pharmaceutical ETF(PPH)